ENTRY       D10214            Mixture   Drug
NAME        Adsorbed diphtheria-purified pertussis-tetanus-inactivated polio combined vaccine;
            Quattrovac (TN);
            Tetrabik (TN)
PRODUCT     KINRIX (GlaxoSmithKline Biologicals SA)
COMPONENT   Bordetella pertussis defense antigen, Diphtheria toxoid [DR:D03926], Tetanus toxoid adsorbed [DR:D05316], Inactivated poliovirus
REMARK      Therapeutic category: 6361
            ATC code: J07CA02
            Product: D10214<JP/US>
EFFICACY    Active immunization
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J07 VACCINES
               J07C BACTERIAL AND VIRAL VACCINES, COMBINED
                J07CA Bacterial and viral vaccines, combined
                 J07CA02 Diphtheria-pertussis-poliomyelitis-tetanus
                  D10214  Adsorbed diphtheria-purified pertussis-tetanus-inactivated polio combined vaccine &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              63  Biological preparations
               636  Mixed biological preparations
                6361  Vaccine and toxoid mixtures
                 D10214  Adsorbed diphtheria-purified pertussis-tetanus-inactivated polio combined vaccine
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10214
DBLINKS     PubChem: 163312245
///
